Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Spain / NCT07244211
Recruiting Not applicable

MAPT Protocol: Fixation Versus Arthroplasty Surgical Treatments for Early Recovery After HIP Fracture (FASTER-HIP)

NCT07244211 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2026-01-23
Last updated
2026-09-30

Condition(s) studied

Femoral Neck Fractures

Investigational drug(s) / intervention(s)

Hip arthroplastyInternal fixation

Hip arthroplasty: Participants will undergo surgical treatment using standard hip arthroplasty techniques for femoral minimally displaced femoral neck fracture. A modern porous-coated press-fit or cemented hip arthroplasty prosthesis will be used at the treating surgeon's discretion. Press-fit implants that have no ingrowth or ongrowth surface will not be permitted. The type of hip prosthesis (hemiarthroplasty or total hip arthroplasty), bearing (single or dual mobility), or the method of arthroplasty fixation (cemented or uncemented) will be at the discretion of the treating surgeon.

Internal fixation: Participants will undergo surgical treatment using standard fixation techniques for minimally displaced femoral neck fractures. The treating surgeon may perform fracture reduction maneuvers if desired. Fixed-angle devices and multiple screws will be permitted. The internal fixation device(s) will be inserted through a small lateral incision. Internal fixation constructs combining cancellous screws and fixed-angle devices will be permitted.

Study summary

This study is an intervention domain of the Musculoskeletal Adaptive Platform Trial. The primary goal of this pragmatic, randomized, open-label, comparative effectiveness trial is to evaluate if arthroplasty is superior to internal fixation when used to treat minimally displaced femoral neck fractures in older adults ≥60 years old. We hypothesize that arthroplasty will reduce death, preserve ambulation, increase days alive and out of hospital, and improve health status compared to internal fixation within 4 months and 12 months from randomization.

Eligibility

Sex
ALL
Min age
60 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * 60 years of age or older undergoing surgery due to a minimally displaced femoral neck fracture * The patient has a health condition affecting physical mobility. * Complete fracture of the femoral neck (AO/OTA 31B) confirmed with anteroposterior and lateral hip radiographs, computed tomography, or magnetic resonance imaging. * Minimally displaced fracture that could be, in the judgment of the attending surgeon, managed with either arthroplasty or in situ internal fixation without reduction. * Low energy injury mechanism. * Surgeons with expertise in internal fixation and total hip arthroplasty or hemiarthroplasty are available to perform surgery. Exclusion Criteria: * The patient is not clinically suitable for either compared treatment. * Expected injury survival of less than 12 months. * Terminal illness with expected survival of less than 12 months. * Incarceration. * Unable to obtain informed consent due to language barriers. * Unable to obtain informed consent because the legally authorized representative was unavailable. * Problems, in the judgment of the study personnel, with maintaining follow-up with the patient. * Currently enrolled in a study or intervention domain that does not permit co-enrollment. * Prior enrollment in the specific platform trial intervention domain. * Patient or legally authorized representative did not provide informed consent (declined participation). * Eligible patient or legally authorized representative was not approached within the screening window (missed participant). * Other reasons to exclude the patient, as approved by the data coordinating center. * Associated lower extremity injury that prevents post-operative weight-bearing. * Retained hardware around the hip that precludes either study treatment. * Infection around the hip (soft tissue or bone). * Pathologic fracture with a lytic lesion in the femoral neck that precludes internal fixation. * Injury did not occur within 21 days of screening. * Patient is too ill, in the judgment of the attending surgeon, for internal fixation. * Patient is too ill, in the judgment of the attending surgeon, for arthroplasty.

Primary outcome measure(s)

Trial sites (31)

FacilityCityRegionStatus
University of California, Irvine Irvine California Recruiting
Los Angeles General Medical Center Los Angeles California Recruiting
University of Southern California Los Angeles California Recruiting
Cedars-Sinai Medical Center Los Angeles California Recruiting
University of California San Francisco San Francisco California Recruiting
University of Miami Miami Florida Not Yet Recruiting
Indiana University Bloomington Indiana Recruiting
University of Maryland, Baltimore - R Adams Cowley Shock Trauma Center Baltimore Maryland Recruiting
University of Maryland Capital Region Health Largo Maryland Recruiting
Beth Israel Deaconess Medical Center Boston Massachusetts Not Yet Recruiting
University of Mississippi University Mississippi Recruiting
NYU Langone Health System New York New York Recruiting
University of Cincinnati Cincinnati Ohio Recruiting
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma Recruiting
St. Luke's University Health System Allentown Pennsylvania Recruiting
Prisma Health-Upstate Greenville South Carolina Recruiting
Vanderbilt University Nashville Tennessee Recruiting
University of Utah Salt Lake City Utah Recruiting
University of Vermont Burlington Vermont Not Yet Recruiting
Inova Health Care Services Fairfax Virginia Recruiting
University of Wisconsin - Madison Madison Wisconsin Recruiting
University of British Columbia Vancouver British Columbia Recruiting
Fraser Health Authority Vancouver British Columbia Recruiting
London Health Sciences Centre London Ontario Recruiting
The Ottawa Hospital Ottawa Canada Not Yet Recruiting
Sykehuset Østfold HF / Østfold Hospital Trust Grålum Norway Recruiting
Hospital Universitario Mutua de Terrassa Barcelona Spain Not Yet Recruiting
Consorci Sanitari de l'Alt Penedès i Garraf (CSAPG) Barcelona Spain Not Yet Recruiting
FRCB-IDIBAPS (Hospital Clinic Barcelona) Barcelona Spain Not Yet Recruiting
Hospital Universitari Vall d'Hebron Barcelona Spain Not Yet Recruiting
University of Edinburgh Edinburgh United Kingdom Not Yet Recruiting

More University of Southern California trials in Spain

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07244211 on ClinicalTrials.gov ↗ ← All trials in Spain